Business · 13/12/2021
FDA Announces Final Guidance for Residual Solvents: Q3C(R8) Impurities
The FDA has released a final guidance for industry on permitted daily exposures for three additional residual solvents, following the International Council for Harmonisation's recommendations, building on the Q3C Impurities: Residual Solvents guidance first introduced in 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →